A new liposomal liver-specific contrast agent for CT: first human phase-I clinical trial assessing efficacy and safety.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/CB3553DF.svg?ark=w1%2F20260515%2FCB3553DF)](https://nobleid.org/work/w1/20260515/CB3553DF)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors